Call for Abstract

Pulmonary hypertension (PH or PHTN) is a condition of increased blood pressure within the arteries of the lungs. The most relevant mechanisms for sudden cardiac death in PAH patients seem to be related to severe dilatation of the pulmonary artery, as subsequent complications, such as left main compression syndrome, pulmonary artery dissection, pulmonary artery rupture, and massive hemoptysis, may take place.
An arterial high blood pressure has the characteristic of pressure indicators, either equal of higher than 140 mm Hg for the systolic or 90 mm Hg for the diastolic pressure, after having repeatedly measured the arterial tension. Essential arterial hypertension is one of the main treatable cardiovascular risk factors. It can be well controlled and the cardiovascular risk reduced through a combination of lifestyle interventions and first-line antihypertensive drugs.

In the pediatric population, hypertension is more commonly observed which is the major cause of mortality and morbidity in many countries.  And long-term health risk to children. It is also noted that there is a correlation between overweight obesity and hypertension and also blood pressure of parents and that of their offspring. Obese children have 3 fold risk of getting hypertension than that of no obese. Children with hypertension should also be screened for cardiovascular disease, including diabetes mellitus and hyperlipidaemia, and should be evaluated for target organ damage with a retinal examination and echocardiography.
The ambulatory blood pressure (ABP) measures used to classify pediatric hypertension and left ventricular mass index (LVMI) in children with true ambulatory hypertension. Pediatric idiopathic intracranial hypertension is a rare condition, but inappropriate diagnosis and management may lead to devastating outcome with loss of vision and lifelong handicap.

Resistance hypertension is high blood pressure that does not respond well to aggressive medical treatment. It is defined as failure to achieve goal blood pressures in patients taking optimal or maximum tolerated doses of three or more antihypertensive drugs, is estimated to occur in about 25% of hypertensive patients on treatment. Several factors have been identified as contributors to resistant hypertension. Poor patient adherence, physician inertia, inadequate doses or inappropriate combinations of antihypertensive drugs, excess alcohol intake, and volume overload are some of the most common causes of resistance.

Renal /Renovascular hypertension caused by a narrowing of the arteries which convey blood to the kidney and which can be controlled by circulatory strain drugs. Individuals with renal hypertension can benefit from outside assistance by stenting, angioplasty, or surgery on the veins of the kidney. Renal hypertension mirrors the connection between blood vessel occlusive sickness and hoisted pulse. More particular determinations are made reflectively when hypertension enhances after intravascular intercession. Renal Hypertension Conference will give the subject are Signs and Side effects of Renal Hypertension, Pathogenesis of Renal Hypertension., Determination and Treatment, Hazard Variables for Renal Hypertension, Renal-supply route Angioplasty and Stenting. High circulatory strain is mostly unsafe as the patients by and large don't encounter the manifestations, so organ harm can happen gradually without being recognized. chronic kidney maladies can be caused by Renal Hypertension .Different strategies have been created to analyse renal hypertension utilizing computerized picture preparing of radiographs.

Gestational hypertension or pregnancy-induced hypertension (PIH) is the development of new hypertension in a pregnant woman after 20 weeks gestation without the presence of protein in the urine or other signs of Pre-eclampsia in pregnancy. It is a temporary diagnosis for hypertensive pregnant women who do not meet criteria for preeclampsia or chronic hypertension (hypertension first detected before the 20th week of pregnancy). The diagnosis is changed to, Preeclampsia, if proteinuria or new signs of end-organ dysfunction develop and chronic (primary or secondary) hypertension, if blood pressure elevation persists ≥12 weeks postpartum.
Gestational Hypertension Workshop related to the subjects are Classification of Pregnancy Induced Hypertension, Risk factors for Gestational Hypertension, Pre-eclampsia and Eclampsia, Pathogenesis of Pre-Eclampsia, Management of Hypertension in Pregnancy, Drug Treatment of Gestational Hypertension, Long Term Cardiovascular Sequelae of Gestational Hypertension.

All heart diseases are cardiovascular diseases, but not all cardiovascular diseases are heart disease. The most common type of heart disease is coronary heart disease. Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. The treatment for heart disease usually includes lifestyle changes.
Heart conditions caused by high blood pressure known as Hypertensive heart disease. Heart problems associated with high blood pressure related to the heart arteries and muscles include narrowing of the arteries called Coronary Heart Disease(CHD) and Thickening and enlargement of the heart called Left Ventricular Hypertrophy(LVH). Both CHD and LVH can lead to heart failure, arrhythmia, ischemia, heart disease, heart attack, sudden cardiac arrest, stroke and sudden death.

Diagnostic trials usually include people who have signs or symptoms of the disease or condition being studied. It refers to trials that are conducted to find better tests or procedures for diagnosing a particular disease or condition.
Hypertension is difficult to manage as the patients are generally symptomless and treatment is preventative rather than palliative. The best way to diagnose hypertension is to measure your blood pressure. If blood pressure is 140/90 mmHg or higher then offer ambulatory blood pressure monitoring (ABPM) to confirm the diagnosis of hypertension. Treatment of hypertension is important for the prevention of cardiovascular and kidney diseases.

Randomized controlled trials have shown that managing hypertension reduces the risk of stroke, coronary artery disease, congestive heart failure, end-stage renal disease, peripheral vascular disease, as well as overall mortality. Despite the inherent health risks associated with uncontrolled hypertension, elevated blood pressure remains inadequately treated in the majority of patients.
Treating high blood pressure includes diet changes, exercise, and medication. Changing lifestyle can lead to control high blood pressure.  The doctor may recommend for a healthy diet with less salt, regular exercise, quit smoking and maintain weight. But sometimes lifestyle changes aren't enough Some treatment and care for hypertension include High blood pressure drug supplement, calcium channel blockers ACE inhibitors, diuretics, beta blocker, omega-3 fish oil supplements etc.

Hypertension is the major risk factor for cardiovascular disease stroke obesity. Lifetime risk estimates for disease condition are more easily understood by the general public compared with other measures of disease Hypertension is an important global health challenge due to its high prevalence and resulting cardiovascular disease and chronic kidney disease. The prevalence of hypertension is relatively very high. Hypertension Risk Factors Conference providing related topics are Controllable Risk Factors, Uncontrollable Risk Factors, Medical Risk Factors, Other Factors.

Hypertension is associated with increased mortality in patients with ischemic heart disease after revascularization with percutaneous coronary intervention. Hypertension is associated with higher mortality in patients with STEMI, NSTEMI/UA or stable angina who are treated with PCI. The outcome in patients undergoing percutaneous coronary intervention in relation to diabetes and hypertension.
People with high blood pressure are more likely to develop coronary artery disease, because high blood pressure puts added force against the artery walls. Over time, this extra pressure can damage the arteries, making them more vulnerable to the narrowing and plaque buildup associated with atherosclerosis